Hidehira Fukaya

Junior Associate Professor

Kitasato University School of Medicine
Country flagJapan
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

Introduction MICRA, a leadless pacemaker system, is an established modality for cardiac pacing. However, its implantation can sometimes be technically challenging. This study aimed to identify anatomical factors associated with procedural difficulty during MICRA implantation, with a particular focus on preoperative CT imaging. Methods We retrospectively analyzed all MICRA implantations performed at our institution from 2018 to 2024. Patients were classified into two groups based on procedural difficulty, defined as a MICRA delivery system in/out time ≥ 30 min and/or three or more MICRA deployment attempts. Logistic regression was used to identify independent predictors of procedural difficulty, which were incorporated into a scoring system. Results Of 122 patients, 111 with available preoperative CT imaging were included (mean age 83 years, 43% female). Procedural difficulty was observed in 37 patients (33%). Independent predictors included right atrial enlargement > 45 mm, right ventricular septal angle > 55° or < 45°, inferior vena cava (IVC)–to–tricuspid valve (TV) angle < 128°, posterior offset from the IVC ostium to the TV < 35 mm (all p < 0.05). A “Difficulty Score” was developed by assigning 1 point for each of the predictors. The score demonstrated excellent discrimination (area under the curve = 0.87). Conclusions Specific anatomical features on preoperative CT are associated with MICRA implantation difficulty. The proposed Difficulty Score may aid in risk stratification and procedural planning.

Year:

2026

Background Catheter ablation (CA) can improve exercise tolerance and quality of life (QOL) in patients with atrial fibrillation (AF). However, its differential effects on muscle strength between paroxysmal AF (PAF) and nonparoxysmal AF (Non‐PAF) remain unclear. Methods We evaluated 94 patients (67.8 ± 10.3 years old, 71% male) who underwent CA (PAF/Non‐PAF 46/48) without AF recurrence. Six‐minute walk distance (6MWD), leg strength, and an AF‐specific QOL questionnaire (AFQLQ) were evaluated at baseline, 3, and 6 months after CA. Results At baseline, the 6MWD and AFQLQ subset 3 score were significantly lower in patients with PAF than in those with Non‐PAF, but the parameters of muscle strength were comparable between the two groups. Both 6MWD and AFQLQ significantly improved at 6 months after CA in both groups. However, leg strength at 6 months after CA significantly improved in the Non‐PAF group (54.9 ± 16.5 to 58.4 ± 15.2, p < .05) but not in the PAF group. Conclusion Successful CA for both PAF and Non‐PAF improved QOL and exercise tolerance. Additionally, CA improved leg strength in Non‐PAF patients.

Year:

2025

Background Despite the positive impact of implantable cardioverter defibrillators (ICDs) and wearable cardioverter defibrillators (WCDs) on prognosis, their implantation is often withheld especially in Japanese heart failure patients with reduced left ventricular ejection fraction (HFrEF) who have not experienced ventricular tachycardia (VT) or ventricular fibrillation (VF) for uncertain reasons. Recent advancements in heart failure (HF) medications have significantly improved the prognosis for HFrEF. Given this context, a critical reassessment of the treatment and prognosis of ICDs and WCDs is essential, as it has the potential to reshape awareness and treatment strategies for these patients. Methods We are initiating a prospective multicenter observational study for HFrEF patients eligible for ICD in primary and secondary prevention, and WCD, regardless of device use, including all consenting patients. Study subjects are to be enrolled from 31 participant hospitals located throughout Japan from April 1, 2023, to December 31, 2024, and each will be followed up for 1 year or more. The planned sample size is 651 cases. The primary endpoint is the rate of cardiac implantable electronic device implementation. Other endpoints include the incidence of VT/VF and sudden death, all‐cause mortality, and HF hospitalization, other events. We will collect clinical background information plus each patient's symptoms, Clinical Frailty Scale score, laboratory test results, echocardiographic and electrocardiographic parameters, and serial changes will also be secondary endpoints. Results Not applicable. Conclusion This study offers invaluable insights into understanding the role of ICD/WCD in Japanese HF patients in the new era of HF medication.

Year:

2024

Background The prognostic impact of atrial fibrillation (AF) and oral anticoagulation (OAC) therapy in patients with type B acute aortic dissection (AAD) remains unclear. Therefore, we investigated the prognostic impact of AF and OAC therapy in patients with type B AAD. Methods Consecutive patients diagnosed with AAD were included in this single‐center, retrospective study. Patients with type B AAD were selected from the study population and divided into three groups: AF(+)/OAC(+), AF(+)/OAC(−), and AF(−)/OAC(−). The primary end point was major adverse cardiovascular and cerebrovascular events (MACCE), including all‐cause death, progressive aortic events, cerebral infarction, and organ malperfusion. Results In total, 139 patients diagnosed with type B AAD were analyzed. AF was observed in 27 patients (19%). Among them, 13 patients (9%) received OAC therapy for AF. MACCE occurred in 32 patients (23%) during the observation period: all‐cause death in four patients, progressive aortic events in 24 patients, cerebral infarction events in two patients, and malperfusion events in two patients. The incidence of MACCE was higher in the AF(+)/OAC(+) group than in the AF(+)/OAC(−) group (hazard ratio[HR]: 3.875; 95% confidence interval [CI]: 1.153–17.496). In contrast, there was no significant difference in the incidence of MACCE between the AF(+)/OAC(−) and AF(−)/OAC(−) groups (HR: 1.001, 95% CI: 0.509–1.802). Conclusion Among patients with type B AAD, the use of OAC for AF was associated with a higher risk of MACCE.

Year:

2024

Introduction: Few non-invasive parameters have been identified for predicting atrial fibrillation (AF) recurrence after catheter ablation (CA). This study aimed to assess the association between AF recurrence and atrial late potentials (ALP) measured using P-wave signal-averaged electrocardiography (P-SAECG). Methods and results: Consecutive patients with paroxysmal AF who underwent first CA at our institution between August 2015 and August 2019 were enrolled. P-SAECG was performed before CA. Two ALP parameters were evaluated: root mean square voltage during the terminal 20 ms (RMS ) and P-wave duration (PWD). Positive ALP was defined as an RMS 115 ms. Patients were divided into the Recurrence and Non-recurrence groups based on AF recurrence at the 1-year follow-up after CA. Of 190 patients (age: 65±11 years, 37% women) enrolled in this study, 21 (11%) had AF recurrence. Positive ALP rate was significantly higher in the Recurrence group than in the Non-Recurrence group (86% vs. 64%, P =0.04) despite there being no differences in other baseline characteristics between the two groups. In the multivariate analysis, positive ALP was an independent predictor of AF recurrence (odds ratio: 3.83, 95% confidence interval: 1.05–14.1, P =0.04). Conclusion: Positive ALP on pre-CA P-SAECG was associated with AF recurrence after CA.

Year:

2024

Collaborators (7)

Ritsushi Kato

-

JAPAN
View details

Takeshi Kato

Kanazawa University

JAPAN
View details

Shinichi Niwano

Clinical Professor

Kitasato University

JAPAN
View details

Morio Shoda

Professor

Tokyo Women's Medical University

JAPAN
View details

Shiro Nakahara

Associate professor

Jichi Medical University Saitama Medical Center

JAPAN
View details

Junya Ako

Kitasato University

JAPAN
View details

Yasuo Okumura

-

JAPAN
View details